LCP · Class II · 21 CFR 864.7470

FDA Product Code LCP: Assay, Glycosylated Hemoglobin

Leading manufacturers include Nova Biomedical Corporation.

249
Total
249
Cleared
146d
Avg days
1978
Since
Declining activity - 1 submissions in the last 2 years vs 2 in the prior period
Review times increasing: avg 931d recently vs 143d historically

FDA 510(k) Cleared Assay, Glycosylated Hemoglobin Devices (Product Code LCP)

249 devices
1–24 of 249

About Product Code LCP - Regulatory Context

510(k) Submission Activity

249 total 510(k) submissions under product code LCP since 1978, with 249 receiving FDA clearance (average review time: 146 days).

Submission volume has declined in recent years - 1 submissions in the last 24 months compared to 2 in the prior period.

FDA Review Time

Recent submissions under LCP have taken an average of 931 days to reach a decision - up from 143 days historically. Manufacturers should account for longer review timelines in current project planning.

LCP devices are reviewed by the Chemistry panel. Browse all Chemistry devices →